title: Differential in vivo effects of a superantigen and an antibody targeted to the same T cell receptor. Activation-induced cell death vs passive macrophage-dependent deletion.
abstract: Superantigens have multiple pleiotropic effects in vivo, causing the activation, proliferation, and deletion of specific T cells. In our study, we analyzed the effects of the bacterial superantigen Staphylococcus aureus enterotoxin B (SEB) on peripheral T cells in vivo. As an internal control we took advantage of a IgG2a mAb, F23.1 (anti-V beta 8), that recognizes products from the same V beta gene family as that recognized by SEB. Suprisingly, not only SEB, but also F23.1 primes peripheral T cells to undergo oligonucleosomal DNA fragmentation typical for programmed cell death (PCD). Nonetheless the deletion and induction of PCD imposed by both agents obey rather different principles. First, SEB, not F23.1-induced PCD, concerns T cells that have passed through the S phase of the cell cycle, as demonstrated by experiments in which the thymidine analogue 5-bromo-2'desoxyuridine was detected in mono- and oligonucleosomal fragments of T cells undergoing PCD. Second, deletion of V beta 8+ T cells induced by SEB, not F23.1, can be blocked in vivo by high doses of retinol and, during the early phase, by glucocorticoid receptor blockade with RU-38486. Inasmuch as retinol fails to antagonize the glucocorticoid-induced PCD, at least two pathways are involved in early SEB-driven deletion, one that depends on the presence of endogenous glucocorticoid, and another that can be inhibited by retinol. Third, depletion of phagocytes in vivo by means of liposome-encapsulated dichloromethylene diphosphonate does not impede the activation and deletion of V beta 8+ cells by SEB, although it partially prevents the elimination of T cells binding F23.1 in vivo. Thus, macrophages are not rate-limiting for the action of SEB. In a further series of experiments, we demonstrate that SEB causes the secretion of a variety of cytokines (IL-1, -2, -4, -10, granulocyte-macrophage-CSF, IFN-gamma, and TNF) that may cause lethal septic shock. In contrast, F23.1 that efficiently induces all these mediators in vitro, fails to do so in vivo. In synthesis, the elimination of T cells induced by two different agents specific for V beta 8 obeys different principles: activation-induced cell death in the case of SEB and passive macrophage-mediated elimination in the case of F23.1.
authors.affiliation: Centro Nacional de Biotecnología (CSIC), Universidad Autónoma de Madrid Campus de Cantoblanco, Spain.
authors.forename: J A
authors.initials: JA
authors.lastname: Gonzalo
authors.forename: E
authors.initials: E
authors.lastname: Baixeras
authors.forename: A
authors.initials: A
authors.lastname: González-García
authors.forename: A
authors.initials: A
authors.lastname: George-Chandy
authors.forename: N
authors.initials: N
authors.lastname: Van Rooijen
authors.forename: C
authors.initials: C
authors.lastname: Martínez
authors.forename: G
authors.initials: G
authors.lastname: Kroemer
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology* / Q000633:toxicity; D017209:Apoptosis; D002478:Cells, Cultured; D016207:Cytokines / Q000096:biosynthesis; D004768:Enterotoxins / Q000037:antagonists & inhibitors / Q000494:pharmacology* / Q000633:toxicity; D008213:Lymphocyte Activation; D008212:Lymphocyte Depletion; D008264:Macrophages / Q000502:physiology*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008808:Mice, Inbred CBA; D015735:Mifepristone / Q000494:pharmacology; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000502:physiology*; D018089:Superantigens / Q000494:pharmacology* / Q000633:toxicity; D013601:T-Lymphocytes / Q000502:physiology*; D014801:Vitamin A / Q000494:pharmacology
chemical_list: D000911:Antibodies, Monoclonal; D016207:Cytokines; D004768:Enterotoxins; D016693:Receptors, Antigen, T-Cell, alpha-beta; D018089:Superantigens; D014801:Vitamin A; D015735:Mifepristone; C031818:enterotoxin B, staphylococcal